J-Lex

Enbrel subcutaneous injection 25mg syringe 0.5mL

Enbrel subcutaneous injection 25mg syringe 0.5mL, developed by Pfizer, features Etanercept (genetical recombination) to manage autoimmune disorders including rheumatoid arthritis and ankylosing spondylitis. This injectable drug is provided as 25mg 0.5mL 1 tube (YJ code: 3999424G1025).

← Back to search

Need more detailed information?

Contact TASAKI PHARMA for inquiries about this medicine (English support available).

Contact us about this drug →

More with the same ingredient

More from this manufacturer